$Palisade Bio (PALI.US)$announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return bowel function following surgery.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
71156064 : I'll get excited when NWBO comes up for review.
BioPharm Insight US OP 71156064 : it's so volatile, trade safe.